TY - JOUR
T1 - Improving naive B cell isolation by absence of CD45RB glycosylation and CD27 expression in combination with BCR isotype
AU - Koers, Jana
AU - Pollastro, Sabrina
AU - Tol, Simon
AU - Niewold, Ilse T. G.
AU - van Schouwenburg, Pauline A.
AU - de Vries, Niek
AU - Rispens, Theo
N1 - Funding Information:
The authors would like to thank Mirjam van der Burg, PhD, for guidance in designing the research and critically reviewing the manuscript. This study was supported by Landsteiner Foundation for Blood Transfusion research (Grant1626).
Publisher Copyright:
© 2022 Wiley-VCH GmbH.
PY - 2022/10
Y1 - 2022/10
N2 - In past years ex vivo and in vivo experimental approaches involving human naive B cells have proven fundamental for elucidation of mechanisms promoting B cell differentiation in both health and disease. For such studies, it is paramount that isolation strategies yield a population of bona fide naive B cells, i.e., B cells that are phenotypically and functionally naive, clonally non-expanded, and have non-mutated BCR variable regions. In this study different combinations of common as well as recently identified B cell markers were compared to isolate naive B cells from human peripheral blood. High-throughput BCR sequencing was performed to analyze levels of somatic hypermutation and clonal expansion. Additionally, contamination from mature mutated B cells intrinsic to each cell-sorting strategy was evaluated and how this impacts the purity of obtained populations. Our results show that current naive B cell isolation strategies harbor contamination from non-naive B cells, and use of CD27-IgD+ is adequate but can be improved by including markers for CD45RB glycosylation and IgM. The finetuning of naive B cell classification provided herein will harmonize research lines using naive B cells, and will improve B cell profiling during health and disease, e.g. during diagnosis, treatment, and vaccination strategies.
AB - In past years ex vivo and in vivo experimental approaches involving human naive B cells have proven fundamental for elucidation of mechanisms promoting B cell differentiation in both health and disease. For such studies, it is paramount that isolation strategies yield a population of bona fide naive B cells, i.e., B cells that are phenotypically and functionally naive, clonally non-expanded, and have non-mutated BCR variable regions. In this study different combinations of common as well as recently identified B cell markers were compared to isolate naive B cells from human peripheral blood. High-throughput BCR sequencing was performed to analyze levels of somatic hypermutation and clonal expansion. Additionally, contamination from mature mutated B cells intrinsic to each cell-sorting strategy was evaluated and how this impacts the purity of obtained populations. Our results show that current naive B cell isolation strategies harbor contamination from non-naive B cells, and use of CD27-IgD+ is adequate but can be improved by including markers for CD45RB glycosylation and IgM. The finetuning of naive B cell classification provided herein will harmonize research lines using naive B cells, and will improve B cell profiling during health and disease, e.g. during diagnosis, treatment, and vaccination strategies.
KW - B cell receptor
KW - CD27
KW - CD45RB glycosylation
KW - Naive B cells
KW - somatic hypermutation
UR - http://www.scopus.com/inward/record.url?scp=85135947951&partnerID=8YFLogxK
U2 - 10.1002/eji.202250013
DO - 10.1002/eji.202250013
M3 - Article
C2 - 35862268
SN - 0014-2980
VL - 52
SP - 1630
EP - 1639
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 10
ER -